Constronics Infra Ltd - Stock Valuation and Financial Performance

BSE: 523844 | NSE: | Hospital & Healthcare Services | Small Cap

Constronics Infra Share Price

133.10 -6.25 -4.49%
as on 21-Nov'24 16:59

DeciZen - make an informed investing decision on Constronics Infra

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality

2. Valuation

Somewhat Undervalued

3. Price Trend

Constronics Infra stock performance -

mw4me loader
P/E Ratio (SA):
93.05
Market Cap:
171.6 Cr.
52-wk low:
14
52-wk high:
157.7

Is Constronics Infra Ltd an attractive stock to invest in?

1. Is Constronics Infra Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Constronics Infra Ltd is a below average quality company.

2. Is Constronics Infra Ltd undervalued or overvalued?

The key valuation ratios of Constronics Infra Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.

3. Is Constronics Infra Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Constronics Infra Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Constronics Infra:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Constronics Infra Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % -6.8%-10.7%-12.1%-14.1%-20.2%-3%11.1%-9.1%11.2%9.9%-
Value Creation
Index
-1.5-1.8-1.9-2.0-2.4-1.2-0.2-1.7-0.2-0.3-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 000000.61.91.52.20.817
Sales YoY Gr.-NANANANANA241.8%-18.6%41.8%-62.2%-
Adj EPS -0.1-0.1-0.1-0.1-0.2-00.1-0.10.20.11.5
YoY Gr.-NANANANANANA-184.6%NA-66.7%-
BVPS (₹) 1.21.10.90.8000.100.30.322.9
Adj Net
Profit
-0.1-0.1-0.1-0.1-0.100.1-0.10.20.12
Cash Flow from Ops. 0000-0.1-0.10.100.10-
Debt/CF from Ops. 0000-5.2-88.968.51159.8-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANA-24.2%-62.2%
Adj EPS NANA-14.9%-66.7%
BVPS-12.8%62.5%37.8%25.9%
Share Price 40.5% 97.7% 143.8% 849.4%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
-6.9-10.8-12.2-14.4-42.4-171.9192.4-138.8167.325.712.6
Op. Profit
Mgn %
00000-4.15-5.55.412.47.3
Net Profit
Mgn %
00000-4.15-5.18.16.910.7
Debt to
Equity
000027.4436.18.546.1530
Working Cap
Days
00000614187185130244356
Cash Conv.
Cycle
00000483-128337

Recent Performance Summary

Debt to equity has declined versus last 3 years average to 2.96

Sales growth is good in last 4 quarters at 5463.69%

Return on Equity has declined versus last 3 years average to 12.60%

Sales growth has been subdued in last 3 years -24.16%

Net Profit has been subdued in last 3 years -14.94%

Latest Financials - Constronics Infra Ltd.

Standalone Consolidated
TTM EPS (₹) 1.5 -
TTM Sales (₹ Cr.) 17.2 -
BVPS (₹.) 22.9 -
Reserves (₹ Cr.) 16 -
P/BV 5.97 -
PE 93.05 -
From the Market
52 Week Low / High (₹) 14.02 / 157.70
All Time Low / High (₹) 0.50 / 157.70
Market Cap (₹ Cr.) 172
Equity (₹ Cr.) 12.5
Face Value (₹) 10
Industry PE 40.5

Management X-Ray of Constronics Infra:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Constronics Infra

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales0000012221
Operating Expenses 0000012221
Manufacturing Costs0000000000
Material Costs0000002120
Employee Cost 0000000000
Other Costs 0000000000
Operating Profit 0000000000
Operating Profit Margin (%) ------4.1%5.0%-5.5%5.4%12.4%
Other Income 0000000000
Interest 0000000000
Depreciation 0000000000
Exceptional Items 0000000000
Profit Before Tax 0000000000
Tax 0000000000
Profit After Tax 0000000000
PAT Margin (%) ------4.1%4.9%-5.1%8.0%6.9%
Adjusted EPS (₹)-0.1-0.1-0.1-0.1-0.20.00.1-0.10.20.1
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 1111000000
Share Capital 7777777777
Reserves -6-6-7-7-7-7-7-7-7-7
Minority Interest0000000000
Debt0000111111
Long Term Debt0000100111
Short Term Debt0000011000
Trade Payables0000000000
Others Liabilities 1111000000
Total Liabilities 1111111111

Fixed Assets

Gross Block0000000000
Accumulated Depreciation0000000000
Net Fixed Assets0000000000
CWIP 0000000000
Investments 0000000000
Inventories0000000000
Trade Receivables0000000000
Cash Equivalents 0000000001
Others Assets1111111110
Total Assets 1111111111

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity 0000000000
PBT 0000000000
Adjustment 0000000000
Changes in Working Capital 00000-0-00-0-0
Tax Paid 0000000000
Cash Flow From Investing Activity 0000000001
Capex 0000000000
Net Investments 0000000000
Others 0000000001
Cash Flow From Financing Activity 0000000000
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0000000000
Interest Paid 0000000000
Dividend Paid 0000000000
Others 0000000000
Net Cash Flow 0000000000
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)-6.88-10.77-12.17-14.42N/AN/AN/AN/AN/AN/A
ROCE (%)-6.78-10.74-12.13-14.1N/AN/AN/AN/AN/AN/A
Asset Turnover Ratio000000.581.81.72.160.77
PAT to CFO Conversion(x)N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Working Capital Days
Receivable Days00000272440743
Inventory Days0000001000
Payable Days000046143384525

Constronics Infra Ltd Stock News

Constronics Infra Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Constronics Infra on 21-Nov-2024 16:59 is ₹133.1.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 21-Nov-2024 16:59 the market cap of Constronics Infra stood at ₹171.6.
The latest P/E ratio of Constronics Infra as of 21-Nov-2024 16:59 is 93.05.
The latest P/B ratio of Constronics Infra as of 21-Nov-2024 16:59 is 5.97.
The 52-week high of Constronics Infra is ₹157.7 and the 52-week low is ₹14.02.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Constronics Infra is ₹17.23 ( Cr.) .

About Constronics Infra Ltd

Invicta Meditek Limited (Invicta) incorporated in 1992 is a Public Limited company engaged in the manufacture of quality Orthopaedic Implants and Instruments.

Invicta Meditek manufacture the quality Orthopaedic Implants and Instruments. Invicta serves the field of Orthopaedics by supplying products for Total Joint Replacement systems, Trauma Implants and Associated Instruments. The product range also includes implants for Hemi-Arthroplasty, all types of Dynamic Compression and round hole plates, Screws with Cortical, Cancellous profiles, special thread sizes and in all diameters (with and without cannulation) and DHS/ DCS systems. The Joint Replacement Systems for Knee, Hip, Shoulder and Ankle are manufactured under license from Endotec Inc., USA.

Invicta has established a full-fledged machine shop with sophisticated, state of the art machinery required to meet the challenging, stringent quality requirements of the Orthopaedic implants and the high levels of accuracy required for the instruments used in joint replacement and other critical surgical operations.

Invicta lays special emphasis on achieving customer satisfaction by demonstrating the ability to consistently provide products that meet and exceed customer requirements. The Quality Control Department is equipped with the latest tools and instruments maintaining the strict quality standards demanded by the orthopaedic community.

Invicta’s product portfolio includes:-Total Joint Replacements for Knee, Hip, Ankle, Shoulder (under license from Endotec Inc., USA) -trauma implants (plates, screws, nails etc) -associated instrumentation

Product range of the company includes:

  • BP Hiflex Knee
  • Hip Implants
  • Trauma Implants
  • Conventional Implants
  • Instruments

Achievements/ recognition :

  • It is an ISO 13485-2003 & CE certified company.
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.